Applied Molecular Therapies

Applied Molecular Therapies Pty Ltd is a joint venture between Cyclotek Pty Ltd and Australian Nuclear Science and Technology Organisation (ANSTO). The company has been established to develop, manufacture and supply TGA/cGMP compliant range of radiopharmaceutical theranostics, initially focussed on the use of the radionuclide 177Lu(n.c.a). As a Contract Development and Manufacturing Organisation (CDMO) for theranostic radiopharmaceuticals in Australia, the company’s aim is to ensure that patients, their families and clinicians can be assured that these therapeutic goods will meet all the safety and quality standards expected of a medicine and the manufacturing process is fully compliant with Australia’s regulatory frameworks for clinical trials, Special Access Scheme and ongoing supply of approved therapeutic goods.